Literature DB >> 12940327

Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.

Ahmed S Samad1, Carol B Lindsley.   

Abstract

Systemic lupus erythematosus is a chronic autoimmune disease of unknown etiology with multisystem involvement. Pulmonary hemorrhage is a major life-threatening manifestation in children and adolescents with systemic lupus erythematosus, as well as in adults. Treatment has traditionally been with high-dose corticosteroids, with or without the addition of cytotoxic agents. We report the response of a patient with childhood systemic lupus erythematosus with recurrent pulmonary hemorrhage to treatment with mycophenolate mofetil.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12940327     DOI： 10.1097/01.SMJ.0000054424.20202.7D

Source DB:  PubMed          Journal:  South Med J        ISSN： 0038-4348            Impact factor:   0.954


  7 in total

1.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 2.  Mycophenolate mofetil in the treatment of systemic lupus erythematosus.

Authors:  Ali Sahin
Journal:  Eurasian J Med       Date:  2009-12

3.  Treatment of intractable pulmonary hemorrhage in two patients with childhood systemic lupus erythematosus.

Authors:  Mohammad Hassan Moradinejad
Journal:  Rheumatol Int       Date:  2009-04-07       Impact factor: 2.631

4.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

Review 5.  Autoimmune mechanisms in children with systemic lupus erythematosus.

Authors:  Dorothee Stichweh; Virginia Pascual
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.686

6.  Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.

Authors:  Anoop M Nambiar; Antonio R Anzueto; Jay I Peters
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

7.  Pulmonary hemosiderosis in children with bronchopulmonary dysplasia.

Authors:  David Kurahara; Marina Morie; Maya Yamane; Sarah Lam; Wallace Matthews; Keolamau Yee; Kara Yamamoto
Journal:  Case Rep Pediatr       Date:  2014-09-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.